Skip to main content
. 2021 Jan;10(1):417–425. doi: 10.21037/tau-20-966

Figure 1.

Figure 1

Flow diagram for recruitment. The flow of study identification and exclusion. mHNPC, monotherapy for hormone naïve metastatic prostate cancer; CRPC, castrate-resistant prostate cancer.